Bridgebio Oncology TherapeutBBOT
13F holders, Q1 2026 (March 31)67holders +15
20new positions
6sold out
3famous investors
$8.95avg. 13F price*
At the end of Q1 2026, 67 institutions reported holding Bridgebio Oncology Therapeut (BBOT) in their 13F filings, up 15 from Q4 2025. 20 opened new positions and 6 sold out. The largest holders were Cormorant Asset Management, LP ($160.0M), Deerfield Management Company, L.P. ($43.7M) and Omega Fund Management, LLC ($29.4M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Bridgebio Oncology Therapeut
- CUSIP
- 107924102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 20 | $17.4M |
| Exits | 6 | $4.7M |
All 13F filers, Q4 2025 → Q1 2026: 3,883,576 shares bought and 4,360,286 shares sold, net −476,710 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 67 holders
| Cormorant Asset Management, LP | 8.07% | No change | 17,878,594 | $160.0M |
| Deerfield Management Company, L.P. | 0.61% | No change | 4,885,446 | $43.7M |
| Omega Fund Management, LLC | 18.05% | No change | 3,289,661 | $29.4M |
| EcoR1 Capital, LLC | 1.08% | No change | 2,823,126 | $25.3M |
| Alphabet Inc. | 0.63% | No change | 2,823,126 | $25.3M |
| Wellington Management Group LLP | 0.00% | Reduce -3.0% | 2,818,348 | $25.2M |
| Enavate Sciences Gp, LLC | 6.69% | No change | 2,626,946 | $23.5M |
| Citadel Advisors | 0.02% | Reduce -0.1% | 2,528,762 | $22.6M |
| Novo Holdings A/S | 1.59% | Add +11.4% | 2,185,923 | $19.6M |
| BlackRock, Inc. | 0.00% | Add +0.2% | 2,088,297 | $18.7M |
| Laurion Capital Management LP | 1.70% | Add +31.2% | 1,922,656 | $17.2M |
| Armistice Capital, LLC | 0.39% | Add +32.8% | 1,328,000 | $11.9M |
| Aisling Capital Management LP | 1.91% | Add +80.3% | 1,018,018 | $9.1M |
| Paradigm Biocapital Advisors LP | 0.16% | Reduce -61.6% | 868,213 | $7.8M |
| Octagon Capital Advisors LP | 0.71% | Reduce -31.1% | 719,000 | $6.4M |
| Royce & Associates LP | 0.06% | New | 636,522 | $5.7M |
| Geode Capital Management, LLC | 0.00% | Add +3.1% | 579,234 | $5.2M |
| Vanguard Capital Management LLC | 0.00% | — | 538,441 | $4.8M |
| Eventide Asset Management, LLC | 0.08% | Reduce -50.0% | 541,181 | $4.7M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -45.5% | 437,889 | $3.9M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | Reduce -71.4% | 400,000 | $3.6M |
| Ensign Peak Advisors, Inc | 0.01% | New | 320,874 | $2.9M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +4.2% | 290,806 | $2.6M |
| Casdin Capital, LLC | 0.19% | No change | 282,312 | $2.5M |
| Ikarian Capital, LLC | 0.35% | Add +22.7% | 270,231 | $2.4M |
| Millennium Management | 0.00% | Add +10.2% | 265,954 | $2.4M |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 254,329 | $2.3M |
| Schroder Investment Management Group | 0.00% | New | 249,161 | $2.2M |
| FMR LLC | 0.00% | No change | 240,300 | $2.2M |
| Granahan Investment Management, LLC | 0.10% | New | 231,040 | $2.1M |
| State Street Corp. | 0.00% | Add +3.7% | 226,278 | $2.0M |
| Goldman Sachs Group Inc. | 0.00% | Add +77.0% | 167,573 | $1.5M |
| Sio Capital Management, LLC | 0.17% | No change | 130,628 | $1.2M |
| Hudson Bay Capital Management LP | 0.01% | New | 110,000 | $985K |
| Woodline Partners LP | 0.00% | No change | 103,707 | $928K |
| Northern Trust Corp. | 0.00% | Add +76.2% | 102,258 | $915K |
| Renaissance Technologies | 0.00% | Add +37.1% | 101,900 | $912K |
| Moore Capital Management, LP | 0.04% | No change | 100,000 | $895K |
| BNP Paribas Financial Markets | 0.00% | Add +243.1% | 90,819 | $813K |
| Tema ETFs LLC | 0.05% | New | 82,172 | $735K |
| Tidal Investments LLC | 0.00% | New | 82,172 | $735K |
| Boothbay Fund Management, LLC | 0.02% | Add +20.7% | 80,884 | $724K |
| HighVista Strategies LLC | 0.19% | Reduce -65.9% | 78,187 | $700K |
| Qube Research & Technologies Ltd | 0.00% | Add +100.1% | 71,925 | $644K |
| XTX Topco Ltd | 0.01% | Add +108.7% | 59,743 | $535K |
| TD Asset Management Inc | 0.00% | Reduce -50.9% | 57,572 | $515K |
| Opaleye Management Inc. | 0.06% | New | 53,282 | $477K |
| UBS Group AG | 0.00% | Reduce -46.0% | 50,450 | $452K |
| ExodusPoint Capital Management, LP | 0.00% | New | 48,122 | $431K |
| Avidity Partners Management LP | 0.08% | New | 43,853 | $392K |
| Morgan Stanley | 0.00% | Add +202.2% | 43,374 | $388K |
| Squarepoint Ops LLC | 0.00% | Add +275.1% | 43,190 | $387K |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -34.1% | 35,692 | $319K |
| Acadian Asset Management LLC | 0.00% | New | 29,148 | $260K |
| Vanguard Global Advisers, LLC | 0.00% | — | 18,163 | $163K |
| Axq Capital, LP | 0.02% | New | 17,347 | $155K |
| Diametric Capital, LP | 0.04% | New | 16,280 | $146K |
| Brevan Howard Capital Management LP | 0.00% | New | 14,248 | $128K |
| Quadrature Capital Ltd | 0.00% | Add +3.3% | 13,351 | $119K |
| Aquatic Capital Management LLC | 0.00% | New | 11,793 | $106K |
| Bellevue Group AG | 0.00% | New | 6,982 | $62K |
| Rockefeller Capital Management L.P. | 0.00% | No change | 700 | $6K |
| Accent Capital Management, LLC | 0.00% | New | 335 | $3K |
| Wells Fargo & Company | 0.00% | No change | 300 | $3K |
| Barclays PLC | 0.00% | New | 212 | $2K |
| Royal Bank of Canada | 0.00% | New | 154 | $1K |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 4 | $36 |
"% of holder's portfolio" is BBOT's weight in each manager's 13F, not the share of Bridgebio Oncology Therapeut the manager owns.